Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Thorax

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.49.11.1099PMID 7831624PMCID PMC475269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toward a cure for osteoporosis: Reversal of excessive bone fragility

  2005cited by this paper
• Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

  1993cited by this paper
• Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

  1992cited by this paper
• Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells

  1992cited by this paper
• The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.

  1991cited by this paper
• Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study.

  1990cited by this paper
• PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS

  1989cited by this paper
• Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

  1988cited by this paper

• Glucocorticoid-induced osteoporosis and Cushing’s syndrome

  2021cites this paper
• Immunsuppressive Therapie und Knochenstoffwechsel nach Nierentransplantation

  2017cites this paper
• Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations

  2017cites this paper
• Glucocorticoid-induced Osteoporosis.

  2016cites this paper
• Treatment and Prevention of Glucocorticoid-Induced Osteoporosis

  2015cites this paper
• Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk

  2015influential citation
• Chapter 49 – Glucocorticoid-Induced Osteoporosis

  2013cites this paper
• Individualizing osteoporosis therapy

  2012cites this paper
• Glucocorticoid-Induced Osteoporosis: Basic Pathological Mechanisms, Clinical Features, and Management in the New Millennium

  2011cites this paper
• Adverse Effects of Corticosteroids on Bone Metabolism: A Review

  2011cites this paper
• Chapter 18, The Spectrum of Pediatric Osteoporosis

  2011cites this paper
• Glucocorticoid Induced Osteoporosis : Update on Treatment Guidelines

  2011cites this paper
• Osteoporosis in young individuals

  2010cites this paper
• 16. Metabolic Bone Disease in Gastrointestinal Disorders

  2010cites this paper
• Glucocorticoid induced osteoporosis

  2010cites this paper
• 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

  2010cites this paper
• [Osteoporosis in young individuals].

  2010cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2010cites this paper
• Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options

  2010cites this paper
• Prevention and treatment of systemic glucocorticoid side effects

  2010cites this paper
• Glucocorticoid-induced osteoporosis

  2009cites this paper
• COPD and osteoporosis

  2009cites this paper
• Enfermedad pulmonar obstructiva crónica y osteoporosis

  2009cites this paper
• CHAPTER 44 – Glucocorticoid-Induced Osteoporosis

  2008cites this paper
• Therapeutic Approaches and Mechanisms of Drug Action

  2008cites this paper
• Fresh®, Calcigamma®, Calcilos®, Calcimax®, Calcit®, calcitonin, Calcitridin®, calcitriol, calcium acetate, calcium aspartate, calcium carbonate, calcium chelate, calcium chloride, calcium citrate, calcium citrate malate, Calcium Dago® (Germany), calcium formate, calcium glucepate, calcium gluconate,

  2007cites this paper
• Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

  2007cites this paper
• Medication-induced osteoporosis

  2007cites this paper
• Glucocorticoid-induced osteoporosis.

  2006cites this paper
• Glucocorticoid-induced osteoporosis: mechanisms and therapeutic approach.

  2006cites this paper
• Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures

  2006cites this paper
• Tratamiento de la osteoporosis en la mujer premenop usica

  2006cites this paper
• review article Glucocorticoid-Induced Osteoporosis

  2006cites this paper
• Prevalence and diagnosis of osteoporosis in patients with systemic lupus erythematosus

  2006cites this paper
• Osteoporosis in health and disease: a dermatologist's perspective.

  2006cites this paper
• Chapter 17 – Calcitonin in the Treatment of Osteoporosis

  2006cites this paper
• Bone Loss in Patients before and after Lung Transplantation

  2005cites this paper
• Drug-induced bone disorders

  2005cites this paper
• In whom and how to prevent glucocorticoid-induced osteoporosis.

  2005cites this paper
• The Climacteric and Osteoporosis in Women with Autoimmune Diseases

  2005cites this paper
• Osteoporosis secundaria a tratamiento con glucocorticoides

  2005cites this paper
• Osteoporosis due to Glucocorticoid Use in Children with Chronic Illness

  2005cites this paper
• Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club

  2005cites this paper
• Osteoporosis secundaria a tratamiento con glucorticoides

  2005cites this paper
• 9. Calcitonin in the treatment of osteoporosis

  2005cites this paper
• Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects

  2005cites this paper
• Calcitonin Therapy in Osteoporosis

  2004cites this paper
• Bone mineral density thresholds for pharmacological intervention to prevent fractures.

  2004cites this paper
• Glucocorticoid-induced osteoporosis: considerations in ophthalmology.

  2004cites this paper
• Osteoporosis en la mujer premenopáusica

  2004cites this paper
• Prevention of Glucocorticoid-induced Osteoporosis

  2004influential citation
• Osteoporosis por glucocorticoides

  2004cites this paper
• The treatment of glucocorticoid-induced osteoporosis.

  2004cites this paper
• 91 – Corticosteroid-Induced Osteoporosis: A Comprehensive Review

  2004cites this paper
• Calcitonin.

  2003cites this paper
• Glucocorticoid-induced osteoporosis.

  2003cites this paper
• Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management.

  2003cites this paper
• Osteoporosis in chronic obstructive pulmonary disease

  2003cites this paper
• Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments.

  2003cites this paper
• Bone metabolism and inflammatory bowel disease

  2003cites this paper
• Lignes directrices de pratique clinique 2002 pour le diagnostic et le traitement de l'ostéoporose au Canada

  2003cites this paper
• CHAPTER 17 – The Spectrum of Pediatric Osteoporosis

  2003cites this paper
• Ostéoporose cortico-induite : données physiopathologiques et thérapeutiques récentes

  2003cites this paper
• Assessment of Risk Factors for Bone Disease in Renal Transplant Recipients

  2002cites this paper
• clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

  2002cites this paper
• Calcitonin in glucocorticoid-induced osteoporosis.

  2002cites this paper
• Corticosteroid-Induced Osteoporosis

  2002cites this paper
• Management of corticosteroid-induced osteoporosis.

  2002cites this paper
• The Comparative Efficacy of Drug Therapies Used for the Management of Corticosteroid‐Induced Osteoporosis: A Meta‐Regression

  2002cites this paper
• [Alphacalcidol in the treatment of osteopenic syndrome in patients with bronchial asthma].

  2002cites this paper
• Steroid-Induced Osteoporosis: Prevention and Management

  2001cites this paper
• [Immunosuppressive therapy and bone metabolism after kidney transplantation].

  2001cites this paper
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.

  2001cites this paper
• Osteoporosis in systemic lupus erythematosus: prevention and treatment

  2001cites this paper
• Corticosteroid-Induced Osteoporosis

  2001cites this paper
• Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.

  2001cites this paper
• Immunsuppressive Therapie und Knochenstoffwechsel nach Nierentransplantation

  2001cites this paper
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis

  2001cites this paper
• Calcitonin.

  2001cites this paper
• Editorial Post-liver transplantation osteoporosis

  2001cites this paper
• Osteoporosis therapies for rheumatoid arthritis patients: minimizing gastrointestinal side effects.

  2001cites this paper
• Post-liver transplantation osteoporosis.

  2001cites this paper
• The pharmacological management of drug-induced rheumatic disorders

  2001cites this paper
• Calcitonin for preventing and treating corticosteroid‐induced osteoporosis

  2000cites this paper
• Calcitonin in the prevention and treatment of glucocorticoid-induced osteoporosis

  2000influential citation
• [Steroid-induced osteoporosis: pathogenesis and therapeutic consequences].

  2000cites this paper
• Management of steroid-induced osteoporosis.

  2000cites this paper
• Glucocorticoid-induced osteoporosis.

  2000cites this paper
• [Chronic obstructive pulmonary diseases and osteoporosis].

  2000cites this paper
• Drug-Induced Bone Loss

  2000cites this paper
• Bone mineral density in women with asthma on long-term inhaled corticosteroid therapy.

  2000cites this paper
• Efficacy of intermittent etidronate therapy for corticosteroid-induced osteoporosis in patients with diffuse connective tissue disease.

  2000cites this paper
• Management of corticosteroid-induced osteoporosis.

  2000cites this paper
• Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.

  2000cites this paper
• A Multidisciplinary Renal Clinic for Corticosteroid‐Induced Bone Disease

  2000cites this paper
• Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis

  2000cites this paper
• Glucocorticoid‐induced osteoporosis

  2000cites this paper
• Prevention of glucocorticoid-induced osteoporosis: provider practice at an urban county hospital.

  1999cites this paper
• Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: A literature review

  1999cites this paper
• Diagnosis and Treatment of Osteoporosis Associated with Immunosuppressive Therapy

  1999cites this paper